Investigators conducted a network meta-analysis of phase 3 trials on MIBC treatments to provide comparative ranking of perioperative therapies.
The FDA accepted an application for Padcev plus Keytruda for patients with muscle-invasive bladder cancer ineligible for ...
About one quarter of patients with muscle-invasive bladder cancer (MIBC) may be treated and derive a benefit with the current standard chemotherapy. To better understand why some tumors resist ...
HOUSTON – July 16, 2025 – Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the cancer more resistant to treatment, according to ...
Education and public awareness are crucial for patients navigating BCG-unresponsive non-muscle invasive bladder cancer treatment options.
What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...
Bladder cancer can be divided into different types, including non-muscle-invasive, muscle-invasive, and metastatic bladder cancer. Chemotherapy and immunotherapy are commonly used treatments, but not ...
From intensifying therapy in ctDNA-positive bladder cancer to scaling it back in ctDNA-negative colon cancer, new data from ...
At a major cancer conference, Merck rolled out some showstoppers — data on drugs on which its business future may depend.
Bladder cancer patients who run out of options often face a grim choice: life-altering surgery to remove the bladder, or living with a disease that might kill them if it spreads to the rest of the ...
Deion Sanders said he thinks has more blood clots due to experiencing leg pain after recently being treated for bladder cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback